Novo Nordisk Free Cash Flow 2010-2024 | NVO

Novo Nordisk free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Novo Nordisk annual free cash flow for 2024 was $10.702B, a 11.31% decline from 2023.
  • Novo Nordisk annual free cash flow for 2023 was $12.066B, a 27.68% increase from 2022.
  • Novo Nordisk annual free cash flow for 2022 was $9.451B, a 22.06% increase from 2021.

Novo Nordisk Free Cash Flow 2010-2024 | NVO

  • Novo Nordisk annual free cash flow for 2024 was $10.702B, a 11.31% decline from 2023.
  • Novo Nordisk annual free cash flow for 2023 was $12.066B, a 27.68% increase from 2022.
  • Novo Nordisk annual free cash flow for 2022 was $9.451B, a 22.06% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B